Multiple inflammatory and catabolic pathways

Multiple inflammatory and catabolic pathways refer to a complex network of signaling cascades and metabolic processes that drive tissue degradation and chronic inflammation (Kapoor et al., 2011, Nature Reviews Rheumatology). These pathways involve various cytokines, such as Tumor necrosis factor-alpha (TNF-alpha) and Interleukin-1 beta (IL-1β), which activate transcription factors like NF-kappaB to induce the expression of degradative enzymes (Wang et al., 2011, NIH/PubMed). These enzymes, including matrix metalloproteinases (MMPs) and ADAMTS, are responsible for the breakdown of extracellular matrix components in conditions like osteoarthritis and rheumatoid arthritis (StatPearls, Inflammation). In addition to joint diseases, these pathways play a critical role in muscle wasting and cachexia by promoting protein degradation via the ubiquitin-proteasome system (NCBI, 2023). Because this term encompasses a wide array of distinct receptors, enzymes, and signaling molecules, it represents a pathological state or mechanism of disease rather than a single, specific therapeutic target (PubChem, 2024). Consequently, while many drugs target individual components within these pathways, the collective term is too broad for precise pharmacological classification and is considered a descriptive category rather than a druggable entity.

Other names

Inflammatory-catabolic axisPro-inflammatory and degradative signalingInflammatory-catabolic state

Not applicable as this represents a broad set of biological processes rather than a single molecular target.